1-7 of 7
Hongbo Yang, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Gilteritinib and Salvage Chemotherapy in FLT3 -Mutated Acute Myeloid Leukemia on the Number Needed to Treat for Various Clinical Outcomes: A Secondary Analysis of the Admiral Trial

Bhavik J. Pandya, PharmD, Cynthia Z. Qi, MBA, Hongbo Yang, PhD, Andy Garnham, MSc, Manasee V. Shah, MPH, Amer M. Zeidan, MBBS, MHS
Journal: Blood
Blood (2020) 136 (Supplement 1): 7.
https://doi.org/10.1182/blood-2020-136184
Published: 2020
Journal Articles

Patient Preferences for Hemophilia a Treatments: A Discrete Choice Experiment

Shawn X. Sun, Jing Zhao, Hongbo Yang, PhD, Eric Wu
Journal: Blood
Blood (2020) 136 (Supplement 1): 22.
https://doi.org/10.1182/blood-2020-134656
Published: 2020
Journal Articles

Treatment Patterns and Healthcare Resource Utilization (HRU) in Patients with Relapsed/Refractory (R/R) FLT3 -Mutated ( FLT3 mut ) and FLT3 -Wild Type ( FLT3 wt ) Acute Myeloid Leukemia (AML): A Multi-Country Medical Chart Study

James D. Griffin, MD, Manasee V Shah, MPH, Yan Song, PhD, Hongbo Yang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4824.
https://doi.org/10.1182/blood-2018-99-110871
Published: 2018
Journal Articles

Treatment Patterns and Healthcare Resource Utilization in Patients with FLT3-Mut and FLT3-Wt Acute Myeloid Leukemia: A Multi-Country Medical Chart Study

James D. Griffin, MD, Hongbo Yang, PhD, Yan Song, PhD, David Kinrich, BSE, Cat N. Bui, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2186.
https://doi.org/10.1182/blood.V130.Suppl_1.2186.2186
Published: 2017
Journal Articles

Characterization of Causal Variants at the GATA3 Loci Associated with Susceptibility to Ph-like Acute Lymphoblastic Leukemia

Hui Zhang, PhD MD, Hongbo Yang, PhD, Tingting Liu, PhD, Maoxiang Qian, PhD, Wenjian Yang, PhD, Kathryn G. Roberts, PhD, Virginia Perez-Andreu, MD PhD, Heng Xu, PhD, Julie M. Gastier-Foster, PhD, Colton Smith, PhD, Ching-Hon Pui, MD, William E. Evans, PharmD, Mary V. Relling, PharmD, Stephen P. Hunger, MD, Charles G. Mullighan, MBBS, MD, Mignon L. Loh, MD, Feng Yue, PhD, Jun J. Yang, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 475.
https://doi.org/10.1182/blood.V130.Suppl_1.475.475
Published: 2017
Journal Articles

Cost-Effectiveness Analysis of CTL019 for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in the United States

Yanni Hao, PhD, Lamis K. Eldjerou, MD, Hongbo Yang, PhD, Cynthia Qi, MBA, Denise Globe, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 609.
https://doi.org/10.1182/blood.V130.Suppl_1.609.609
Published: 2017
Journal Articles

Costs per Month Free of Progression or Death of Targeted Therapies in the Treatment of Relapsed/Refractory Multiple Myeloma

Hongbo Yang, PhD, Anuja Roy, PhD, Chelsey Yang, Evangeline McDonald, Arun Krishna, PhD, Emil T Kuriakose, MD, Denise Globe, PhD, David Siegel, MD PhD, Sundar Jagannath, MD
Journal: Blood
Blood (2015) 126 (23): 5369.
https://doi.org/10.1182/blood.V126.23.5369.5369
Published: 2015